ÑéÖ¤ÐÔʵÑé,verified experimentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂÁ¹ý¸ººÉ,Aluminum overloadÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Åàѵ·½°¸,training schemeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°¸ÀýÑ¡Ôñ,case selectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·çÏÕ¹ÜÀí´ëÊ©,risk management measureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹«¿ªÍ¸Ã÷,Open and TransparentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿â´æÖÜתÂÊ,inventory turnoverÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·Î°ÐÏò¸øÒ©ÏµÍ³,Lung Targeting Drug Delivery SystemÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶³¸ÉÈé,Lyophilized emulsionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÓÒ±¶ËûÃ×ËÉÁ×ËáįעÉäÒº,Dexbetamethasone Sodium Phosphate InjectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
HIV-1ÕûºÏøÒÖÖÆ¼Á,HIV-1 integrase inhibitorsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈýµªßòÑÜÉúÎï,triazole derivativesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½µÑªÑ¹»îÐÔ,antihypertensive activityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³õ²½Ò©Ð§Ñ§,preliminary pharmacodynamicsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÑÎËáÇ¿Á¦Ã¹ËØ,Doxycycline hydrochlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÏõËáïØ,gallium nitrateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÏõËá²¼¿µßò,Butoconazole nitrateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿¨Î¬µØÂ寬,Carvedilol TabletsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉúÎï𤸽΢Çò,bioadhesive microspheresÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ƥ·ôͶҩ,cutaneous administrationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
º¬Á¿¿ØÖÆ,content controlÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈÜÕÍËÙÂÊ,hydrated rateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µâÀë×ÓÑ¡Ôñµç¼«,Iodide ion-selective electrodeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
̼ÄÉÃ×¹ÜÐÞÊε缫,carbon nanotubes modified glassy carbon electrodeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈýάÔ×Ó³¡È«Ï¢×÷ÓÃʸÁ¿(3D-HoVAIF),three-dimensional holographic vector of atomic interaction field(3D-HoVAIF)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÑôÀë×ÓÊ÷Ö¬,cation resinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈܼÁ²ÐÁô,Residual SolventÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±½ÒÒͪËá,Phenylglyoxylic acidÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼·³ö¹öÔ²·¨,extrusion-spheronizationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
îéĤµç¼«,bismuth-film electrodeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´ÙÄý¼Á,coagulantÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÖØ¾ù·Ö×ÓÁ¿,weight average molecular weightÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÑÎËáÆÕĪ¿¨Òò,pramoxine hydrochlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶ÔôÇ»ù±½ÒÒ´¼,p-hydroxyphenylethyl alcoholÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿¹ÒÖÓô»îÐÔ,antidepressant activityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈܼÁ²ÐÁôÁ¿,solvent residueÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÆÀ¼ÛÄÚÈÝ,Evaluation contentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ABC·ÖÎö·¨,ABC analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
º¬Áò°±»ùËá,sulfur-containing amino acidsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶àôÇ»ùçÞ´¼,polyhydroxy sterolÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Áò»¯ïÓÁ¿×Óµã,CdS quantum dotsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Áã¿â´æ¹ÜÀí,zero inventory managementÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ò©Æ·ÖÊÁ¿,Drug qualityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
öÑÓã,spanish mackerelÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
À©É¢³Ø,Diffusion chamberÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
΢ÈéÒºÏàÉ«Æ×,Microemulsion liquid chromatographyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹û½º¸Æ,calcium pectinateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÇàÃ¹ËØV¼ØÆ¬,Phenoxymethylpenicillin Potassium TabletsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Òõ¡¢ÑôÀë×Ó,anions and cationsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Îȶ¨ÐÔ¿¼²ì,stability testÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉúÎï𤸽Ƭ,bioadhesive tabletsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ãð¾ú×¢ÉäÓÃË®,sterile water for injectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±ÇÅç¼Á,nasal sprayÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ò½ÓÃÑõ,medical oxygenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÎÞË®ÑÇÁòËáÄÆ,anhydrous sodium sulfiteÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÅçÎí¸ÉÔïÈé¼Á,spray-dried emulsionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÎÞ¾ú¹¤ÒÕ,aseptic processingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÑÎËá°ëë×°±Ëá,Cysteine HydrochlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
΢·ÖµçλÈܳö,differential potentiometric stripping analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·´ÏàÐü¸¡·¨,inverse suspension methodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹Ï¶ú½º,guar gumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
MgCl2,magnesium chlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÖÊÁ¿¿¼²ì,quality investigationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒºÌå¶¥¿ÕÆøÏàÉ«Æ×·¨,Solution headspace gas chromatographyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ƕ¶Î¹²¾ÛÎï½ºÊø,block copolymer micellesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÒ´¼ÈܼÁ²ÐÁô,residual ethanol solventÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿ÚÇ»À£ÑñĤ,oral ulcer filmÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ôDZû»ù¼×»ùÏËÎ¬ËØÁÚ±½¶þ¼×Ëáõ¥,hydroxypropyl methylcellulose phthalateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÑÎËá¶þÇâ°£ÍзÈ,Dihydroetorphine hydrochlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒõÀë×Ó½»»»²ãÎö,Anion exchange chromatographyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
CoreyÄÚõ¥,Corey lactoneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
È黯-ÈܼÁ»Ó·¢·¨,emulsion-solvent evaporation methodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³¦ÈܽºÄÒ,Enteric-coated capsulesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ó㾫µ°°×Äý¾Û·¨,protamine aggregation methodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°ü½á²ð·Ö,inclusion resolutionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÖØÁ¿²îÒì,weight variationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»ùÖÊÅä·½,media formulaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸»ÂíËá¸£ÄªÌØÂÞ,formoterol fumarateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³¬ÉùÓÕµ¼,ultrasonic inductionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÁÙ´²¹¤×÷,clinical workÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×÷ÓÃÌØµã,action charactersÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
É«¸ÊËáÄÆ,sodium cromoglycateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×î¼Ñ×éºÏ,best combinationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐÁ·¥Ëû͡Ƭ,Simvastatin TabletsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÑÎËáÀ×ŵàº,Ranolazine hydrochlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸¨Ã¸¢ñ,nicotinamide adenine dinucleotideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÖлªÑÛ¾µÉßÉß¶¾,Chinese Cobra venomÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶³¸É¼¼Êõ,freeze-drying technologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂíÀ´Ëáäå±½ÄÇÃô,brompheniramine maleateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸´·½ÌæÏõßòº¬ÊþÒº,Compound Tinidazole GarglesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½áºÏ²ÎÊý,binding parametersÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ò©Æ·Ñз¢,Drug Research and DevelopmentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
PPAR¼¤¶¯¼Á,PPAR agonistÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
άCÒøÇÌÆ¬,vitamin C Yinqiao tabletÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄáÃÀÊæÀûƬ,Nimesulide tabletsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÑÎËáŵ·úɳÐÇ,norfloxacin hydrochlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×¢ÉäÓû¹ÔÐ͹Èë׸ÊëÄ,Reduced Glutathione for InjectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
H/D½»»»,H/D exchangeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
D-°±»ùÆÏÌÇÑÎËáÑÎ,D-glucosamine hydrochlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
éÙÇàù,Penicillium citrinumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«

|